Dr. Khaled Al-Mousa, founder of Saudi Bio and founder of the vaccine manufacturing company, explained via a tweet on his account on the X platform that construction work on the human vaccine factory began at the beginning of this year. This factory is considered the first of its kind in the Kingdom and the largest .in the Middle East
Dr. Al-Mousa said: “Thanks be to God Almighty, today we have started construction work on the human vaccine factory project after two years of diligent work on engineering and technical preparations. We are proud of our step towards enhancing our capabilities in vaccine manufacturing, and we are striving to “.achieve the Kingdom’s Vision 20/30
He added: “Over the course of 17 years, we have succeeded in localizing the manufacture of insulin and cancer treatment drugs, and today we are adding the vaccine industry to our list of achievements. This “.factory will enhance national health security and meet market needs
Al-Mousa expressed his thanks and appreciation to the wise leadership, saying: “I thank our wise leadership for the support and facilities they have provided, which enabled us to achieve these dreams. We “.are committed to actively participating in achieving the goals of the National Biotechnology Strategy
Dr. Al-Mousa stressed that the factory will have a major impact on the future of the vaccine industry in the .region, wishing success to all those working in this national project.
